Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer

NCT00905021 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Sponsor withdrew support

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Exemestane
DRUG: Sutent

Sponsor

Baylor Breast Care Center

Collaborators

[object Object]